fda compounding restrictions bpc-157 Repost @peptides with @use.repost γ»γ»γ» BREAKING NEWS! Today's 8β6 advisory vote for is one of the biggest peptide regulatory developments we've seen in years. While nothing changes immediately, the recommendation represents π¨ BREAKING: U.S. Regulators to
BREAKING: U.S. Regulators to Review Controversial Peptides Backed by RFK Jr. U.S. health regulators are preparing to review whether several controversial peptide compounds should be allowed to be made by compounding The experts will take votes on whether the FDA should allow seven popular peptides to be added to a list of substances that are safe for compounding by pharmacies. The FDA cracked down on BPC 157 and now the biohackers are losing their minds 3 FOR 3. An FDA advisory committee has now voted 86, with one abstention, to recommend BPC 157, KPV and TB 500 for inclusion on the 503A Bulks List. This is not FDA approval
Pay in 4 interest-free payments of $6.50 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 4 - Aug 9
